KMG Fiduciary Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.24M | Buy |
5,529
+491
| +10% | +$199K | 0.17% | 126 |
|
|
2025
Q1 | $2.51M | Buy |
5,038
+503
| +11% | +$250K | 0.21% | 107 |
|
|
2024
Q4 | $2.36M | Buy |
4,535
+567
| +14% | +$295K | 0.2% | 110 |
|
|
2024
Q3 | $2.45M | Buy |
3,968
+178
| +5% | +$110K | 0.21% | 105 |
|
|
2024
Q2 | $2.1M | Buy |
3,790
+149
| +4% | +$82.4K | 0.21% | 96 |
|
|
2024
Q1 | $2.12M | Buy |
3,641
+234
| +7% | +$136K | 0.22% | 98 |
|
|
2023
Q4 | $1.81M | Buy |
3,407
+103
| +3% | +$54.7K | 0.21% | 103 |
|
|
2023
Q3 | $1.67M | Buy |
3,304
+207
| +7% | +$105K | 0.22% | 108 |
|
|
2023
Q2 | $1.62M | Buy |
3,097
+128
| +4% | +$66.8K | 0.21% | 114 |
|
|
2023
Q1 | $1.71M | Buy |
2,969
+38
| +1% | +$21.9K | 0.25% | 105 |
|
|
2022
Q4 | $1.61M | Buy |
2,931
+83
| +3% | +$45.7K | 0.27% | 98 |
|
|
2022
Q3 | $1.44M | Sell |
2,848
-122
| -4% | -$61.9K | 0.28% | 93 |
|
|
2022
Q2 | $1.61M | Buy |
2,970
+136
| +5% | +$73.9K | 0.3% | 83 |
|
|
2022
Q1 | $1.67M | Buy |
2,834
+66
| +2% | +$39K | 0.27% | 87 |
|
|
2021
Q4 | $1.85M | Sell |
2,768
-235
| -8% | -$157K | 0.29% | 86 |
|
|
2021
Q3 | $1.72M | Buy |
3,003
+86
| +3% | +$49.1K | 0.29% | 82 |
|
|
2021
Q2 | $1.47M | Buy |
2,917
+54
| +2% | +$27.3K | 0.26% | 83 |
|
|
2021
Q1 | $1.31M | Buy |
+2,863
| New | +$1.31M | 0.25% | 82 |
|